nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Dyspnoea—Cisplatin—testicular cancer	0.00145	0.00145	CcSEcCtD
Perflutren—Skin disorder—Etoposide—testicular cancer	0.00144	0.00144	CcSEcCtD
Perflutren—Dry skin—Doxorubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Perflutren—Hyperhidrosis—Etoposide—testicular cancer	0.00144	0.00144	CcSEcCtD
Perflutren—Diarrhoea—Dactinomycin—testicular cancer	0.00141	0.00141	CcSEcCtD
Perflutren—Gastrointestinal disorder—Cisplatin—testicular cancer	0.0014	0.0014	CcSEcCtD
Perflutren—Vomiting—Bleomycin—testicular cancer	0.0014	0.0014	CcSEcCtD
Perflutren—Hypotension—Etoposide—testicular cancer	0.00139	0.00139	CcSEcCtD
Perflutren—Rash—Bleomycin—testicular cancer	0.00139	0.00139	CcSEcCtD
Perflutren—Pain—Cisplatin—testicular cancer	0.00139	0.00139	CcSEcCtD
Perflutren—Dermatitis—Bleomycin—testicular cancer	0.00139	0.00139	CcSEcCtD
Perflutren—Hypersensitivity—Ifosfamide—testicular cancer	0.00139	0.00139	CcSEcCtD
Perflutren—Conjunctivitis—Methotrexate—testicular cancer	0.00136	0.00136	CcSEcCtD
Perflutren—Asthenia—Ifosfamide—testicular cancer	0.00135	0.00135	CcSEcCtD
Perflutren—Eosinophilia—Doxorubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Perflutren—Feeling abnormal—Cisplatin—testicular cancer	0.00134	0.00134	CcSEcCtD
Perflutren—Paraesthesia—Etoposide—testicular cancer	0.00134	0.00134	CcSEcCtD
Perflutren—Pruritus—Ifosfamide—testicular cancer	0.00133	0.00133	CcSEcCtD
Perflutren—Dyspnoea—Etoposide—testicular cancer	0.00133	0.00133	CcSEcCtD
Perflutren—Nausea—Bleomycin—testicular cancer	0.00131	0.00131	CcSEcCtD
Perflutren—Vomiting—Dactinomycin—testicular cancer	0.00131	0.00131	CcSEcCtD
Perflutren—Rash—Dactinomycin—testicular cancer	0.0013	0.0013	CcSEcCtD
Perflutren—Diarrhoea—Ifosfamide—testicular cancer	0.00129	0.00129	CcSEcCtD
Perflutren—Gastrointestinal disorder—Etoposide—testicular cancer	0.00128	0.00128	CcSEcCtD
Perflutren—Body temperature increased—Cisplatin—testicular cancer	0.00128	0.00128	CcSEcCtD
Perflutren—Fatigue—Etoposide—testicular cancer	0.00128	0.00128	CcSEcCtD
Perflutren—Neuropathy peripheral—Epirubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Perflutren—Pain—Etoposide—testicular cancer	0.00127	0.00127	CcSEcCtD
Perflutren—Conjunctivitis—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Perflutren—Haemoglobin—Methotrexate—testicular cancer	0.00126	0.00126	CcSEcCtD
Perflutren—Haemorrhage—Methotrexate—testicular cancer	0.00125	0.00125	CcSEcCtD
Perflutren—Dizziness—Ifosfamide—testicular cancer	0.00125	0.00125	CcSEcCtD
Perflutren—Pharyngitis—Methotrexate—testicular cancer	0.00124	0.00124	CcSEcCtD
Perflutren—Feeling abnormal—Etoposide—testicular cancer	0.00123	0.00123	CcSEcCtD
Perflutren—Nausea—Dactinomycin—testicular cancer	0.00122	0.00122	CcSEcCtD
Perflutren—Gastrointestinal pain—Etoposide—testicular cancer	0.00122	0.00122	CcSEcCtD
Perflutren—Visual impairment—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Perflutren—Vomiting—Ifosfamide—testicular cancer	0.0012	0.0012	CcSEcCtD
Perflutren—Hypersensitivity—Cisplatin—testicular cancer	0.0012	0.0012	CcSEcCtD
Perflutren—Bradycardia—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Perflutren—Rash—Ifosfamide—testicular cancer	0.00119	0.00119	CcSEcCtD
Perflutren—Dermatitis—Ifosfamide—testicular cancer	0.00119	0.00119	CcSEcCtD
Perflutren—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Perflutren—Urticaria—Etoposide—testicular cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Haemoglobin—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Rhinitis—Epirubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Abdominal pain—Etoposide—testicular cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Body temperature increased—Etoposide—testicular cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Conjunctivitis—Doxorubicin—testicular cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Haemorrhage—Epirubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Perflutren—Eye disorder—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Perflutren—Tinnitus—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Perflutren—Hypoaesthesia—Epirubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Perflutren—Asthenia—Cisplatin—testicular cancer	0.00116	0.00116	CcSEcCtD
Perflutren—Pharyngitis—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Perflutren—Cardiac disorder—Methotrexate—testicular cancer	0.00116	0.00116	CcSEcCtD
Perflutren—Connective tissue disorder—Epirubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Perflutren—Angiopathy—Methotrexate—testicular cancer	0.00114	0.00114	CcSEcCtD
Perflutren—Immune system disorder—Methotrexate—testicular cancer	0.00113	0.00113	CcSEcCtD
Perflutren—Visual impairment—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Perflutren—Mediastinal disorder—Methotrexate—testicular cancer	0.00113	0.00113	CcSEcCtD
Perflutren—Chills—Methotrexate—testicular cancer	0.00113	0.00113	CcSEcCtD
Perflutren—Nausea—Ifosfamide—testicular cancer	0.00112	0.00112	CcSEcCtD
Perflutren—Diarrhoea—Cisplatin—testicular cancer	0.00111	0.00111	CcSEcCtD
Perflutren—Bradycardia—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Perflutren—Eye disorder—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Perflutren—Hypersensitivity—Etoposide—testicular cancer	0.0011	0.0011	CcSEcCtD
Perflutren—Tinnitus—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Erythema—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Haemoglobin—Doxorubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Cardiac disorder—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Flushing—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Rhinitis—Doxorubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Haemorrhage—Doxorubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Hypoaesthesia—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Perflutren—Pharyngitis—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Perflutren—Dysgeusia—Methotrexate—testicular cancer	0.00107	0.00107	CcSEcCtD
Perflutren—Asthenia—Etoposide—testicular cancer	0.00107	0.00107	CcSEcCtD
Perflutren—Connective tissue disorder—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Perflutren—Angiopathy—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Perflutren—Immune system disorder—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Perflutren—Mediastinal disorder—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Perflutren—Back pain—Methotrexate—testicular cancer	0.00106	0.00106	CcSEcCtD
Perflutren—Chills—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Pruritus—Etoposide—testicular cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Arrhythmia—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Visual impairment—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Vomiting—Cisplatin—testicular cancer	0.00103	0.00103	CcSEcCtD
Perflutren—Vision blurred—Methotrexate—testicular cancer	0.00103	0.00103	CcSEcCtD
Perflutren—Rash—Cisplatin—testicular cancer	0.00102	0.00102	CcSEcCtD
Perflutren—Dermatitis—Cisplatin—testicular cancer	0.00102	0.00102	CcSEcCtD
Perflutren—Erythema—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Perflutren—Diarrhoea—Etoposide—testicular cancer	0.00102	0.00102	CcSEcCtD
Perflutren—Eye disorder—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Perflutren—Ill-defined disorder—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Perflutren—Tinnitus—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Perflutren—Cardiac disorder—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Perflutren—Flushing—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Perflutren—Dysgeusia—Epirubicin—testicular cancer	0.001	0.001	CcSEcCtD
Perflutren—Back pain—Epirubicin—testicular cancer	0.000988	0.000988	CcSEcCtD
Perflutren—Angiopathy—Doxorubicin—testicular cancer	0.000985	0.000985	CcSEcCtD
Perflutren—Malaise—Methotrexate—testicular cancer	0.000985	0.000985	CcSEcCtD
Perflutren—Dizziness—Etoposide—testicular cancer	0.000984	0.000984	CcSEcCtD
Perflutren—Muscle spasms—Epirubicin—testicular cancer	0.000982	0.000982	CcSEcCtD
Perflutren—Immune system disorder—Doxorubicin—testicular cancer	0.000981	0.000981	CcSEcCtD
Perflutren—Vertigo—Methotrexate—testicular cancer	0.000981	0.000981	CcSEcCtD
Perflutren—Mediastinal disorder—Doxorubicin—testicular cancer	0.000979	0.000979	CcSEcCtD
Perflutren—Leukopenia—Methotrexate—testicular cancer	0.000977	0.000977	CcSEcCtD
Perflutren—Chills—Doxorubicin—testicular cancer	0.000974	0.000974	CcSEcCtD
Perflutren—Arrhythmia—Doxorubicin—testicular cancer	0.00097	0.00097	CcSEcCtD
Perflutren—Nausea—Cisplatin—testicular cancer	0.000964	0.000964	CcSEcCtD
Perflutren—Vision blurred—Epirubicin—testicular cancer	0.000963	0.000963	CcSEcCtD
Perflutren—Cough—Methotrexate—testicular cancer	0.000953	0.000953	CcSEcCtD
Perflutren—Ill-defined disorder—Epirubicin—testicular cancer	0.000948	0.000948	CcSEcCtD
Perflutren—Convulsion—Methotrexate—testicular cancer	0.000946	0.000946	CcSEcCtD
Perflutren—Vomiting—Etoposide—testicular cancer	0.000946	0.000946	CcSEcCtD
Perflutren—Erythema—Doxorubicin—testicular cancer	0.000945	0.000945	CcSEcCtD
Perflutren—Agitation—Epirubicin—testicular cancer	0.000939	0.000939	CcSEcCtD
Perflutren—Rash—Etoposide—testicular cancer	0.000938	0.000938	CcSEcCtD
Perflutren—Dermatitis—Etoposide—testicular cancer	0.000937	0.000937	CcSEcCtD
Perflutren—Headache—Etoposide—testicular cancer	0.000932	0.000932	CcSEcCtD
Perflutren—Arthralgia—Methotrexate—testicular cancer	0.000929	0.000929	CcSEcCtD
Perflutren—Chest pain—Methotrexate—testicular cancer	0.000929	0.000929	CcSEcCtD
Perflutren—Myalgia—Methotrexate—testicular cancer	0.000929	0.000929	CcSEcCtD
Perflutren—Dysgeusia—Doxorubicin—testicular cancer	0.000926	0.000926	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000923	0.000923	CcSEcCtD
Perflutren—Malaise—Epirubicin—testicular cancer	0.000921	0.000921	CcSEcCtD
Perflutren—Discomfort—Methotrexate—testicular cancer	0.000918	0.000918	CcSEcCtD
Perflutren—Vertigo—Epirubicin—testicular cancer	0.000918	0.000918	CcSEcCtD
Perflutren—Syncope—Epirubicin—testicular cancer	0.000916	0.000916	CcSEcCtD
Perflutren—Leukopenia—Epirubicin—testicular cancer	0.000915	0.000915	CcSEcCtD
Perflutren—Back pain—Doxorubicin—testicular cancer	0.000914	0.000914	CcSEcCtD
Perflutren—Muscle spasms—Doxorubicin—testicular cancer	0.000909	0.000909	CcSEcCtD
Perflutren—Palpitations—Epirubicin—testicular cancer	0.000903	0.000903	CcSEcCtD
Perflutren—Loss of consciousness—Epirubicin—testicular cancer	0.000898	0.000898	CcSEcCtD
Perflutren—Cough—Epirubicin—testicular cancer	0.000892	0.000892	CcSEcCtD
Perflutren—Anaphylactic shock—Methotrexate—testicular cancer	0.000891	0.000891	CcSEcCtD
Perflutren—Vision blurred—Doxorubicin—testicular cancer	0.000891	0.000891	CcSEcCtD
Perflutren—Convulsion—Epirubicin—testicular cancer	0.000885	0.000885	CcSEcCtD
Perflutren—Nausea—Etoposide—testicular cancer	0.000884	0.000884	CcSEcCtD
Perflutren—Hypertension—Epirubicin—testicular cancer	0.000882	0.000882	CcSEcCtD
Perflutren—Ill-defined disorder—Doxorubicin—testicular cancer	0.000877	0.000877	CcSEcCtD
Perflutren—Nervous system disorder—Methotrexate—testicular cancer	0.000874	0.000874	CcSEcCtD
Perflutren—Chest pain—Epirubicin—testicular cancer	0.00087	0.00087	CcSEcCtD
Perflutren—Myalgia—Epirubicin—testicular cancer	0.00087	0.00087	CcSEcCtD
Perflutren—Arthralgia—Epirubicin—testicular cancer	0.00087	0.00087	CcSEcCtD
Perflutren—Agitation—Doxorubicin—testicular cancer	0.000869	0.000869	CcSEcCtD
Perflutren—Skin disorder—Methotrexate—testicular cancer	0.000865	0.000865	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000864	0.000864	CcSEcCtD
Perflutren—Hyperhidrosis—Methotrexate—testicular cancer	0.000861	0.000861	CcSEcCtD
Perflutren—Discomfort—Epirubicin—testicular cancer	0.000859	0.000859	CcSEcCtD
Perflutren—Malaise—Doxorubicin—testicular cancer	0.000853	0.000853	CcSEcCtD
Perflutren—Dry mouth—Epirubicin—testicular cancer	0.000851	0.000851	CcSEcCtD
Perflutren—Vertigo—Doxorubicin—testicular cancer	0.000849	0.000849	CcSEcCtD
Perflutren—Syncope—Doxorubicin—testicular cancer	0.000848	0.000848	CcSEcCtD
Perflutren—Leukopenia—Doxorubicin—testicular cancer	0.000846	0.000846	CcSEcCtD
Perflutren—Palpitations—Doxorubicin—testicular cancer	0.000835	0.000835	CcSEcCtD
Perflutren—Anaphylactic shock—Epirubicin—testicular cancer	0.000834	0.000834	CcSEcCtD
Perflutren—Oedema—Epirubicin—testicular cancer	0.000834	0.000834	CcSEcCtD
Perflutren—Hypotension—Methotrexate—testicular cancer	0.000833	0.000833	CcSEcCtD
Perflutren—Loss of consciousness—Doxorubicin—testicular cancer	0.000831	0.000831	CcSEcCtD
Perflutren—Cough—Doxorubicin—testicular cancer	0.000825	0.000825	CcSEcCtD
Perflutren—Shock—Epirubicin—testicular cancer	0.00082	0.00082	CcSEcCtD
Perflutren—Convulsion—Doxorubicin—testicular cancer	0.000819	0.000819	CcSEcCtD
Perflutren—Nervous system disorder—Epirubicin—testicular cancer	0.000818	0.000818	CcSEcCtD
Perflutren—Hypertension—Doxorubicin—testicular cancer	0.000816	0.000816	CcSEcCtD
Perflutren—Tachycardia—Epirubicin—testicular cancer	0.000814	0.000814	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000812	0.000812	CcSEcCtD
Perflutren—Skin disorder—Epirubicin—testicular cancer	0.00081	0.00081	CcSEcCtD
Perflutren—Hyperhidrosis—Epirubicin—testicular cancer	0.000806	0.000806	CcSEcCtD
Perflutren—Chest pain—Doxorubicin—testicular cancer	0.000805	0.000805	CcSEcCtD
Perflutren—Myalgia—Doxorubicin—testicular cancer	0.000805	0.000805	CcSEcCtD
Perflutren—Arthralgia—Doxorubicin—testicular cancer	0.000805	0.000805	CcSEcCtD
Perflutren—Paraesthesia—Methotrexate—testicular cancer	0.0008	0.0008	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000799	0.000799	CcSEcCtD
Perflutren—Discomfort—Doxorubicin—testicular cancer	0.000795	0.000795	CcSEcCtD
Perflutren—Dyspnoea—Methotrexate—testicular cancer	0.000794	0.000794	CcSEcCtD
Perflutren—Dry mouth—Doxorubicin—testicular cancer	0.000787	0.000787	CcSEcCtD
Perflutren—Dyspepsia—Methotrexate—testicular cancer	0.000784	0.000784	CcSEcCtD
Perflutren—Hypotension—Epirubicin—testicular cancer	0.000779	0.000779	CcSEcCtD
Perflutren—Oedema—Doxorubicin—testicular cancer	0.000772	0.000772	CcSEcCtD
Perflutren—Anaphylactic shock—Doxorubicin—testicular cancer	0.000772	0.000772	CcSEcCtD
Perflutren—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000769	0.000769	CcSEcCtD
Perflutren—Fatigue—Methotrexate—testicular cancer	0.000768	0.000768	CcSEcCtD
Perflutren—Pain—Methotrexate—testicular cancer	0.000762	0.000762	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00076	0.00076	CcSEcCtD
Perflutren—Shock—Doxorubicin—testicular cancer	0.000759	0.000759	CcSEcCtD
Perflutren—Nervous system disorder—Doxorubicin—testicular cancer	0.000757	0.000757	CcSEcCtD
Perflutren—Tachycardia—Doxorubicin—testicular cancer	0.000753	0.000753	CcSEcCtD
Perflutren—Skin disorder—Doxorubicin—testicular cancer	0.000749	0.000749	CcSEcCtD
Perflutren—Paraesthesia—Epirubicin—testicular cancer	0.000749	0.000749	CcSEcCtD
Perflutren—Hyperhidrosis—Doxorubicin—testicular cancer	0.000746	0.000746	CcSEcCtD
Perflutren—Dyspnoea—Epirubicin—testicular cancer	0.000743	0.000743	CcSEcCtD
Perflutren—Feeling abnormal—Methotrexate—testicular cancer	0.000734	0.000734	CcSEcCtD
Perflutren—Dyspepsia—Epirubicin—testicular cancer	0.000734	0.000734	CcSEcCtD
Perflutren—Gastrointestinal pain—Methotrexate—testicular cancer	0.000729	0.000729	CcSEcCtD
Perflutren—Hypotension—Doxorubicin—testicular cancer	0.000721	0.000721	CcSEcCtD
Perflutren—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00072	0.00072	CcSEcCtD
Perflutren—Fatigue—Epirubicin—testicular cancer	0.000719	0.000719	CcSEcCtD
Perflutren—Pain—Epirubicin—testicular cancer	0.000713	0.000713	CcSEcCtD
Perflutren—Urticaria—Methotrexate—testicular cancer	0.000708	0.000708	CcSEcCtD
Perflutren—Abdominal pain—Methotrexate—testicular cancer	0.000704	0.000704	CcSEcCtD
Perflutren—Body temperature increased—Methotrexate—testicular cancer	0.000704	0.000704	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000703	0.000703	CcSEcCtD
Perflutren—Paraesthesia—Doxorubicin—testicular cancer	0.000693	0.000693	CcSEcCtD
Perflutren—Dyspnoea—Doxorubicin—testicular cancer	0.000688	0.000688	CcSEcCtD
Perflutren—Feeling abnormal—Epirubicin—testicular cancer	0.000687	0.000687	CcSEcCtD
Perflutren—Gastrointestinal pain—Epirubicin—testicular cancer	0.000682	0.000682	CcSEcCtD
Perflutren—Dyspepsia—Doxorubicin—testicular cancer	0.000679	0.000679	CcSEcCtD
Perflutren—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000666	0.000666	CcSEcCtD
Perflutren—Fatigue—Doxorubicin—testicular cancer	0.000665	0.000665	CcSEcCtD
Perflutren—Urticaria—Epirubicin—testicular cancer	0.000662	0.000662	CcSEcCtD
Perflutren—Pain—Doxorubicin—testicular cancer	0.00066	0.00066	CcSEcCtD
Perflutren—Abdominal pain—Epirubicin—testicular cancer	0.000659	0.000659	CcSEcCtD
Perflutren—Body temperature increased—Epirubicin—testicular cancer	0.000659	0.000659	CcSEcCtD
Perflutren—Hypersensitivity—Methotrexate—testicular cancer	0.000656	0.000656	CcSEcCtD
Perflutren—Asthenia—Methotrexate—testicular cancer	0.000639	0.000639	CcSEcCtD
Perflutren—Feeling abnormal—Doxorubicin—testicular cancer	0.000636	0.000636	CcSEcCtD
Perflutren—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000631	0.000631	CcSEcCtD
Perflutren—Pruritus—Methotrexate—testicular cancer	0.00063	0.00063	CcSEcCtD
Perflutren—Hypersensitivity—Epirubicin—testicular cancer	0.000614	0.000614	CcSEcCtD
Perflutren—Urticaria—Doxorubicin—testicular cancer	0.000613	0.000613	CcSEcCtD
Perflutren—Abdominal pain—Doxorubicin—testicular cancer	0.00061	0.00061	CcSEcCtD
Perflutren—Body temperature increased—Doxorubicin—testicular cancer	0.00061	0.00061	CcSEcCtD
Perflutren—Diarrhoea—Methotrexate—testicular cancer	0.00061	0.00061	CcSEcCtD
Perflutren—Asthenia—Epirubicin—testicular cancer	0.000598	0.000598	CcSEcCtD
Perflutren—Pruritus—Epirubicin—testicular cancer	0.00059	0.00059	CcSEcCtD
Perflutren—Dizziness—Methotrexate—testicular cancer	0.000589	0.000589	CcSEcCtD
Perflutren—Diarrhoea—Epirubicin—testicular cancer	0.000571	0.000571	CcSEcCtD
Perflutren—Hypersensitivity—Doxorubicin—testicular cancer	0.000568	0.000568	CcSEcCtD
Perflutren—Vomiting—Methotrexate—testicular cancer	0.000567	0.000567	CcSEcCtD
Perflutren—Rash—Methotrexate—testicular cancer	0.000562	0.000562	CcSEcCtD
Perflutren—Dermatitis—Methotrexate—testicular cancer	0.000561	0.000561	CcSEcCtD
Perflutren—Headache—Methotrexate—testicular cancer	0.000558	0.000558	CcSEcCtD
Perflutren—Asthenia—Doxorubicin—testicular cancer	0.000554	0.000554	CcSEcCtD
Perflutren—Dizziness—Epirubicin—testicular cancer	0.000551	0.000551	CcSEcCtD
Perflutren—Pruritus—Doxorubicin—testicular cancer	0.000546	0.000546	CcSEcCtD
Perflutren—Vomiting—Epirubicin—testicular cancer	0.00053	0.00053	CcSEcCtD
Perflutren—Nausea—Methotrexate—testicular cancer	0.000529	0.000529	CcSEcCtD
Perflutren—Diarrhoea—Doxorubicin—testicular cancer	0.000528	0.000528	CcSEcCtD
Perflutren—Rash—Epirubicin—testicular cancer	0.000526	0.000526	CcSEcCtD
Perflutren—Dermatitis—Epirubicin—testicular cancer	0.000525	0.000525	CcSEcCtD
Perflutren—Headache—Epirubicin—testicular cancer	0.000522	0.000522	CcSEcCtD
Perflutren—Dizziness—Doxorubicin—testicular cancer	0.00051	0.00051	CcSEcCtD
Perflutren—Nausea—Epirubicin—testicular cancer	0.000495	0.000495	CcSEcCtD
Perflutren—Vomiting—Doxorubicin—testicular cancer	0.000491	0.000491	CcSEcCtD
Perflutren—Rash—Doxorubicin—testicular cancer	0.000486	0.000486	CcSEcCtD
Perflutren—Dermatitis—Doxorubicin—testicular cancer	0.000486	0.000486	CcSEcCtD
Perflutren—Headache—Doxorubicin—testicular cancer	0.000483	0.000483	CcSEcCtD
Perflutren—Nausea—Doxorubicin—testicular cancer	0.000458	0.000458	CcSEcCtD
